Wednesday, February 14, 2018

FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint - FDA Press Releases

FDA approves Erleada (apalutamide), first treatment for non-metastatic, castration-resistant prostate cancer

from Food and Drug Administration--Press Releases http://ift.tt/2Ep57D2
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)